

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hematologic neoplasms | D019337 | — | — | — | — | 1 | — | — | 1 |
| Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
| Drug common name | Pelabresib |
| INN | pelabresib |
| Description | Pelabresib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target bromodomain-containing protein 4. |
| Classification | Small molecule |
| Drug class | extra-terminal motif (BET) family of bromodomain (BRD) proteins |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | Cc1noc2c1-c1ccccc1C(c1ccc(Cl)cc1)=N[C@H]2CC(N)=O |
| PDB | — |
| CAS-ID | 1380087-89-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4303404 |
| ChEBI ID | — |
| PubChem CID | 57389999 |
| DrugBank | DB17129 |
| UNII ID | U4017GUQ06 (ChemIDplus, GSRS) |

